NICE may issue final guidance on use of injectables to treat migraines within a month

The body tasked with providing advice to the NHS and healthcare professionals about new drugs could issue final guidelines on the use of Botox to treat chronic migraines within one month. The National Institute for Health and Clinical Excellence (NICE) has decided that the injectable can be used as a treatment, and registered stakeholders now have until May 25 to put forward any objections. If none are received, final guidance could be released in the next month, according to a report by the Press Association.Botox is widely known as a cosmetic treatment for frown lines and crows' feet. However, if the final draft guidelines are approved, it will be made available to NHS patients who suffer from headaches on at least 15 days a month. Professor Carole Longson, director of the Health Technology Evaluation Centre at NICE, said: "Chronic migraines are extremely debilitating and can significantly affect a person's quality of life. "We are pleased that the committee has been able to recommend Botox as a preventative therapy for those adults whose headaches have not improved despite trying at least three other medications and whose headaches are not caused by medication overuse." See here for original article: http://www.nursingtimes.net/nursing-practice/clinical-specialisms/neurology/botox-closer-to-being-approved-for-migraine-treatment/5044806.article?blocktitle=News&contentID=4385